Markets
← Back to Stocks
KR
KROGER CO
Consumer Staples · Food Retail
$73.78
+0.61%
Vol: 0.2M
Araverus Market Read
Thursday, March 19, 2026
Q4 revenue growth of 2.1% and Eli Lilly Zepbound pharmacy partnership expansion support momentum
Kroger (KR) remained relatively flat in extended trading with after-hours decline of 0.43% to $73.59 and minimal pre-market movement, as investors digested strong Q4 results showing revenue of $34.7 billion (+2.1% YoY) and gross margin improvement of 23.1%. The grocer added a new competitive advantage by offering Eli Lilly's Zepbound weight-management injectable through Kroger pharmacies, tapping into high-margin pharmacy services. Despite some store closures, analysts remain positive with raised price targets.
Price 50d 200d
Previous Market Reads
2 of 2 days↑
Sector Peers
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| WMTWALMART | $121.08 | -0.80% | -6.0% | 36.9x | 0.66 | $965.4B |
| COSTCOSTCO | $974.70 | -0.44% | -3.7% | 43.4x | 0.99 | $432.5B |
| PGPROCTER | $144.86 | -1.36% | -9.2% | 19.8x | 0.34 | $339.0B |
| KOCOCA | $75.61 | -0.48% | -4.4% | 21.8x | 0.33 | $325.0B |
| PMPHILIP | $163.36 | -1.67% | -11.0% | 17.8x | 0.40 | $254.3B |
| PEPPEPSICO | $152.72 | -0.55% | -4.8% | 16.7x | 0.38 | $208.8B |
| MOALTRIA | $65.07 | -0.09% | -2.2% | 11.2x | 0.43 | $109.2B |
| MDLZMONDELEZ | $56.50 | -0.09% | -5.6% | 16.7x | 0.37 | $72.9B |
| MNSTMONSTER | $73.76 | -0.19% | -11.1% | 28.9x | 0.44 | $72.1B |
Fundamentals
Market Cap$45.3B
P/E (TTM)47.9
Forward P/E13.1
Beta0.59
Div Yield191.00%
Prev Close$73.34
RSI (14-Day)
67Neutral
0305070100
52-Week Range
$58.60$73.78$76.58
From High-3.7%
From Low+25.9%
Moving Averages
50d SMA
$67.05+10.0%
200d SMA
$66.83+10.4%
Price above both MAs — bullish structure.
Returns
1W
-1.6%
1M
+7.1%
3M
+19.4%
6M
+11.3%
1Y
+14.1%
YTD
+17.8%
Volume
Today165K
20d Avg6.9M
Ratio0.02x